Completed PHASE4 INTERVENTIONAL 4-arm NCT00000437

Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)

Nalmefene in Nicotine and Alcohol Dependence

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Interventions Naltrexone Tablet and Nicotine Patch Naltrexone Tablet and Placebo Patch Placebo Tablet and Nicotine Patch Placebo Tablet and Placebo Patch

Updated 6 times since 2017 Last updated: Apr 18, 2017 Started: Sep 26, 1997 Primary completion: Sep 15, 2005 Completion: Sep 15, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00000437, this PHASE4 trial focuses on Alcoholism and Smoking and remains completed. Sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), it has been updated 6 times since 1997, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
May 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — May 2017 [monthly]

Completed PHASE4

First recorded

Sep 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
The Scripps Research Institute

Data source: The Scripps Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Miami, United States